Neurology:Case report:脑脊液过度分流致可逆性执行障碍综合征一例

2022-08-04 Naomi MedSci原创

正常压力性脑积水是一种可逆性的神经疾患。近日,一则发表在Neurology上的Case report报道了一例由脑室-腹腔分流术导致的正常压力性脑积水患者。

近日,一则发表在Neurology上的Case report报道了一例由脑脊液过度分流导致的正常压力性脑积水。

一位72岁的男性科学教师在6次脑室-腹腔分流术后1年出现正常压力性脑积水,伴有颈部疼痛、行为改变和非遗忘性认知下降。6个月前,他的分流术从4变成了3。MoCA 为21/30,其中88个为异常执行优势。脑电图没有异常。脑脊液 AD 生物标志物处于临界状态。MRI 89[图1]发现过度分流。经过分流调整(3-4) ,他的认知和行为90症状得到缓解。4个月后重复 MoCA 为29/30,1年后持续缓解。颅内低压,无论是 VP 分流还是自发性脑脊液漏(1,2) ,都可能引起可逆性执行障碍性认知障碍。

在双侧额叶上方,反映了颅内压低。一年随访MRI C)显示桥脑前池(细箭头)的正常化,垂体窝凸缘(箭头)的减少和双侧额叶上方的硬脑膜增强(箭头) D)的减少,表明进行性分辨的柱头相关的颅内低压。

文献来源:Maneval J, Dmytriw AA, Acar D. Reversible Dysexecutive Syndrome From CSF Overshunting in a Patient With Normal Pressure Hydrocephalus [published online ahead of print, 2022 Jun 15]. Neurology. 2022;10.1212/WNL.0000000000200942. doi:10.1212/WNL.0000000000200942

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
    2023-06-10 charl1234567
  2. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
    2023-04-01 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
    2022-08-04 cyfguvgi

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2027972, encodeId=dc4d202e9720c, content=<a href='/topic/show?id=7c9a41324e' target=_blank style='color:#2F92EE;'>#case#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4132, encryptionId=7c9a41324e, topicName=case)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Sat Jun 10 18:37:33 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001890, encodeId=3e7920018901b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 01 07:37:33 CST 2023, time=2023-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782646, encodeId=17331e82646f1, content=<a href='/topic/show?id=cff1413333' target=_blank style='color:#2F92EE;'>#case report#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4133, encryptionId=cff1413333, topicName=case report)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Aug 14 04:37:33 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236585, encodeId=9ee1123658568, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKgrnf67D3ddbalXADDrBnicULYYIn4tjz2jTiagbqHqFntDkYCVkE7WnVnz26n6XXUk4hTmFR8iczDQ/132, createdBy=4e9f5263713, createdName=cyfguvgi, createdTime=Thu Aug 04 15:02:41 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432353, encodeId=275e14323530d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580262, encodeId=e4b215802624b, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624995, encodeId=e8af162499584, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Tue Aug 02 09:37:33 CST 2022, time=2022-08-02, status=1, ipAttribution=)]
    2022-08-02 yaanren

相关资讯

成人脑室-腹腔分流术后的晚期感染并发症(4例报告并文献复习)

脑室-腹腔分流(ventriculoperitoneal shunt,VP分流)术是目前治疗交通性脑积水的主要手术方式;其操作步骤成熟,治疗效果确切。但是,大型流行病学调查发现,术后感染性并发症的发生

脑积水脑室-腹腔分流术后帕金森综合征3例临床分析

男性,41岁,主因头痛2年余,饮水呛咳、吞咽困难、构音不清1月余,于2004年10月18日入院。

NEJM:正常压力脑积水脑室-腹腔分流术治疗-病例报道

正常压力脑积水典型表现为尿失禁、步态障碍和痴呆。脑脊液分流术是主要的治疗方法。

拓展阅读

European Radiology:半定量MR特征对特发性正常压力脑积水分流术后预后的预测价值

现阶段,传统的结构成像在特发性正常压力脑积水(iNPH)的诊断和预后中的准确性和实用性仍有争议。

Neurology:特发性正常压力脑积水的血管危险因素有哪些?

INPH患者有更多的VRFs,以及在一般人群中缺乏保护性因素。几乎有25%的INPH患者可能被VRFs所解释。这表明INPH可能是血管性痴呆的一种亚型。有针对性改良VRFs的干预措施可能对INPH有有益的效应

Neurology:特发性正常压力脑积水(iNPH)的心血管因素

研究人员就血管危险因素和白质病变(WMLs)研究了疑似特发性正常压力脑积水(iNPH)的临床和影像学检查结果,使用了有代表性的人群为基础的样本进行巢式病例对照研究。从人群为基础的样本中,研究人员在1986年至2000年间对1235名年龄在70岁以上的参与者进行了CT和大脑的检查。研究人员确定了55人脑积水脑室扩大,也就是说,影像学结果与iNPH是一致的。其中,26人的临床症状是符合疑似iNPH国际